Wednesday, 22 January 2020

First U.S. approval of cannabis-based drug

25 June 2018 | News

The company is seeking approval to use the drug to treat Lennox-Gastaut and Dravet syndromes, which cause uncontrolled daily seizures and put patients at high risk for other physical and intellectual disabilities, injury and early death.

 Singapore - A drug to treat childhood epilepsy is expected this week to become the first medicine derived from cannabis to be approved for sale in the U.S.

GW Pharmaceuticals has raised $1B from American healthcare funds during the past five years to develop Epidiolex.

FDA clearance would pave the way for the drug to be launched nationwide by the fall.

Sign up for the editor pick and get articles like this delivered right to your inbox.

Editors Pick
+Country Code-Phone Number(xxx-xxxxxxx)


Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account



Podcast

 

Survey Box

Is 2020 demanding timely action of technology adoption in healthcare?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls